Cynomolgus CRTAM/CD355 protein (Recombinant) (C-hFc) (STJP020250)

SPECIFICATIONS
HostHEK293 cells
ConjugationUnconjugated
ImmunogenRecombinant Cynomolgus CRTAM/CD355 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ser18-Gly287) of Cynomolgus CRTAM/CD355 (Accession #) fused with hFc tag at the C-terminal.
STJP020250-100
๐Ÿšš Free UK Delivery on orders over ยฃ150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRecombinant-Cynomolgus CRTAM/CD355-C-hFc protein was developed in hek293 cells using the region Ser18-Gly287. For use in research applications.
HostHEK293 cells
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ConjugationUnconjugated
Storage InstructionStore at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Determination Method< 1 EU/Mu g of the protein by LAL method.

Target Information

ImmunogenRecombinant Cynomolgus CRTAM/CD355 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ser18-Gly287) of Cynomolgus CRTAM/CD355 (Accession #) fused with hFc tag at the C-terminal.
Immunogen RegionSer18-Gly287
Immunogen SequenceSLTNHTETITVEEGQTLTLK CVTSLRKSSSLQWLTPSGFT IFLNEYPAFKNSRYQLLHHS ANQLSISVSNITLQDEGVYK CLHYSDSVSTKEVKVIVLAT PFKPILEASVIRKQNGEEHV VLMCSAMRSKPPPQITWLLG NGVEVSGGTHHEFETDGKKC NTTSTLIIHTYGKNSTVDCI IRHRGLQGRKLVAPFRFEDL VTDEETASDALERNSVSSQD PQQPTSTVSVMEDSSTLEI

Additional Info

Background Class-I Restricted T Cell-Associated Molecule (CRTAM) is a protein that is expressed after T cell activation. The interaction of CRTAM with its ligand, nectin-like 2 (Necl2) , is required for the efficient production of IL-17, IL-22, and IFN Gamma by murine CD4 T cells, and it plays a role in optimal CD8 T and NK cell cytotoxicity. CRTAM promotes the pro-inflammatory cytokine profile; therefore, it may take part in the immunopathology of autoimmune diseases such as diabetes type 1 or colitis.

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins